WEST PHARMACEUTICAL SERVICES, INC. (WST) Total liabilities 2016–2025
WEST PHARMACEUTICAL SERVICES, INC. (WST) total liabilities at each fiscal year-end, per SEC filings.
$1.1BFY2025 · since FY2016: $599.2M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +13.8% |
| FY2024 | $961.1M | +1.3% |
| FY2023 | $948.5M | +1.8% |
| FY2022 | $931.9M | -4.8% |
| FY2021 | $978.4M | +4.2% |
| FY2020 | $939.3M | +22.3% |
| FY2019 | $768.2M | +31.9% |
| FY2018 | $582.6M | -0.1% |
| FY2017 | $582.9M | -2.7% |
| FY2016 | $599.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice